For instance, under glucose-limited conditions, it was observed that acute myeloid leukemia (AML) cells 35, pancreatic cancer cells 36, and lung cancer cells 34 augment fructose metabolism through enhanced expression and activity of the fructose transporter GLUT5, supporting malignant proliferation. The gene discussed is SLC2A5; the disease is pancreatic neoplasm.